152 related articles for article (PubMed ID: 24587102)
1. A porphodimethene chemical inhibitor of uroporphyrinogen decarboxylase.
Yip KW; Zhang Z; Sakemura-Nakatsugawa N; Huang JW; Vu NM; Chiang YK; Lin CL; Kwan JY; Yue S; Jitkova Y; To T; Zahedi P; Pai EF; Schimmer AD; Lovell JF; Sessler JL; Liu FF
PLoS One; 2014; 9(2):e89889. PubMed ID: 24587102
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of uroporphyrinogen decarboxylase from Bacillus subtilis.
Fan J; Liu Q; Hao Q; Teng M; Niu L
J Bacteriol; 2007 May; 189(9):3573-80. PubMed ID: 17122346
[TBL] [Abstract][Full Text] [Related]
3. Direct assay of enzymes in heme biosynthesis for the detection of porphyrias by tandem mass spectrometry. Uroporphyrinogen decarboxylase and coproporphyrinogen III oxidase.
Wang Y; Gatti P; Sadílek M; Scott CR; Turecek F; Gelb MH
Anal Chem; 2008 Apr; 80(7):2599-605. PubMed ID: 18294003
[TBL] [Abstract][Full Text] [Related]
4. Investigations of rat liver uroporphyrinogen decarboxylase. Comparisons of porphyrinogens I and III as substrates and the inhibition by porphyrins.
Smith AG; Francis JE
Biochem J; 1981 Apr; 195(1):241-50. PubMed ID: 7306050
[TBL] [Abstract][Full Text] [Related]
5. Purification and properties of the uroporphyrinogen decarboxylase from Rhodobacter sphaeroides.
Jones RM; Jordan PM
Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):703-12. PubMed ID: 8352737
[TBL] [Abstract][Full Text] [Related]
6. Purification and properties of human erythrocyte uroporphyrinogen decarboxylase: immunological demonstration of the enzyme defect in porphyria cutanea tarda.
Sassa S; de Verneuil H; Anderson KE; Kappas A
Trans Assoc Am Physicians; 1983; 96():65-75. PubMed ID: 6437037
[TBL] [Abstract][Full Text] [Related]
7. A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.
Phillips JD; Bergonia HA; Reilly CA; Franklin MR; Kushner JP
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5079-84. PubMed ID: 17360334
[TBL] [Abstract][Full Text] [Related]
8. Measurement of uroporphyrinogen decarboxylase activity.
Phillips JD; Kushner JP
Curr Protoc Toxicol; 2001 May; Chapter 8():Unit 8.4. PubMed ID: 20954157
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two assay methods for activities of uroporphyrinogen decarboxylase and coproporphyrinogen oxidase.
Jones MA; Thientanavanich P; Anderson MD; Lash TD
J Biochem Biophys Methods; 2003 Mar; 55(3):241-9. PubMed ID: 12706908
[TBL] [Abstract][Full Text] [Related]
10. Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.
Ito E; Yue S; Moriyama EH; Hui AB; Kim I; Shi W; Alajez NM; Bhogal N; Li G; Datti A; Schimmer AD; Wilson BC; Liu PP; Durocher D; Neel BG; O'Sullivan B; Cummings B; Bristow R; Wrana J; Liu FF
Sci Transl Med; 2011 Jan; 3(67):67ra7. PubMed ID: 21270338
[TBL] [Abstract][Full Text] [Related]
11. The first branching point in porphyrin biosynthesis: a systematic docking, molecular dynamics and quantum mechanical/molecular mechanical study of substrate binding and mechanism of uroporphyrinogen-III decarboxylase.
Bushnell EA; Erdtman E; Llano J; Eriksson LA; Gauld JW
J Comput Chem; 2011 Apr; 32(5):822-34. PubMed ID: 20941734
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic inactivation of red cell uroporphyrinogen decarboxylase by porphyrins.
Batlle AM; de Salamanca RE; Chinarro S; Afonso SG; Stella AM
Int J Biochem; 1986; 18(2):143-7. PubMed ID: 3949059
[TBL] [Abstract][Full Text] [Related]
13. Characterization and crystallization of human uroporphyrinogen decarboxylase.
Phillips JD; Whitby FG; Kushner JP; Hill CP
Protein Sci; 1997 Jun; 6(6):1343-6. PubMed ID: 9194196
[TBL] [Abstract][Full Text] [Related]
14. A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors.
Tsou YA; Chen KC; Chang SS; Wen YR; Chen CY
J Biomol Struct Dyn; 2013 Dec; 31(12):1358-69. PubMed ID: 23140436
[TBL] [Abstract][Full Text] [Related]
15. Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.
Weiss Y; Chen B; Yasuda M; Nazarenko I; Anderson KE; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):363-366. PubMed ID: 30514647
[TBL] [Abstract][Full Text] [Related]
16. Localisation of Plasmodium falciparum uroporphyrinogen III decarboxylase of the heme-biosynthetic pathway in the apicoplast and characterisation of its catalytic properties.
Nagaraj VA; Arumugam R; Chandra NR; Prasad D; Rangarajan PN; Padmanaban G
Int J Parasitol; 2009 Apr; 39(5):559-68. PubMed ID: 19041871
[TBL] [Abstract][Full Text] [Related]
17. Expression and characterization of six clinically relevant uroporphyrinogen decarboxylase gene mutations.
Christiansen L; Brøns-Poulsen J; Hørder M; Brock A; Petersen NE
Scand J Clin Lab Invest; 2005; 65(3):227-35. PubMed ID: 16095052
[TBL] [Abstract][Full Text] [Related]
18. An effective chromatographic separation of chicken red blood cell coproporphyrinogen oxidase and uroporphyrinogen decarboxylase, two enzymes in heme biosynthesis.
Jones MA; Taneja M; Xu Y; Chung W; Stob CM; Lash TD
Bioorg Med Chem Lett; 2004 Nov; 14(22):5559-64. PubMed ID: 15482924
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for tetrapyrrole coordination by uroporphyrinogen decarboxylase.
Phillips JD; Whitby FG; Kushner JP; Hill CP
EMBO J; 2003 Dec; 22(23):6225-33. PubMed ID: 14633982
[TBL] [Abstract][Full Text] [Related]
20. The influence of carbamazepine on the heme biosynthetic pathway.
Schoenfeld N; Greenblat Y; Epstein O; Atsmon A
Biochem Med; 1985 Dec; 34(3):280-6. PubMed ID: 4096716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
